CTI BIOPHARMA CORP·4

Mar 23, 6:47 PM ET

CTI BIOPHARMA CORP 4

4 · CTI BIOPHARMA CORP · Filed Mar 23, 2016

Insider Transaction Report

Form 4
Period: 2016-03-21
Plunkett Matthew
EVP, Corporate Development
Transactions
  • Tax Payment

    Common Stock

    2016-03-21$0.55/sh63,874$35,016526,210 total
Footnotes (1)
  • [F1]Represents shares withheld by CTIC to satisfy minimum tax withholding obligations on the vesting of restricted stock.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT